SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-21-005442
Filing Date
2021-05-17
Accepted
2021-05-17 18:31:09
Documents
2
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3304
2 ex24sherman20210323.txt EX-24 4221
  Complete submission text file 0001179110-21-005442.txt   8940
Mailing Address C/O IDM PHARMA, INC. 9 PARKER, SUITE 100 IRVINE CA 92618
Business Address
SHERMAN JEFFREY W (Reporting) CIK: 0001230482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37569 | Film No.: 21933068

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Issuer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
SIC: 2834 Pharmaceutical Preparations